What Criteria Should Aesthetic Practitioners Use To Select Wavelengths And Pulse Durations When Treating Leg Veins Versus Superficial Facial Telangiectasia With Vascular Laser Systems? Optimize Vascular Laser Treatments With Expert Guidance

Match the wavelength and pulse duration to vessel depth and diameter. For superficial facial telangiectasia, practitioners generally favor strongly hemoglobin-absorbed, shorter wavelengths such as 532 nm KTP, 585–595 nm pulsed-dye laser, or selected IPL systems, with relatively short pulses around 5–10 ms when appropriate. Leg veins are usually deeper and larger, so they more often require 755 nm Alexandrite or 1,064 nm long-pulsed Nd:YAG, with pulse durations increasing from approximately 5–20 ms for smaller veins to 30–60 ms for larger vessels.

The governing principle is selective photothermolysis: choose a wavelength that reaches the vessel and is absorbed by its blood, then choose a pulse duration that is comparable to the vessel’s thermal relaxation time. Facial vessels are usually superficial and fine; leg veins are typically deeper, larger, and more thermally demanding.

Start With the Vessel, Not the Device

Estimate depth and diameter

Wavelength selection should begin with the target vessel’s depth, caliber, blood composition, and surrounding skin characteristics.

Facial telangiectasias commonly occupy the superficial dermis and may measure roughly 60–200 micrometers, although facial vascular lesions can span a broader range. Leg telangiectasias and reticular veins are often deeper and may measure approximately 0.3–1.0 mm.

Use hemoglobin absorption as a guide

Vascular lasers work by delivering light that is preferentially absorbed by blood and converted into heat. Important absorption regions include the green range around 532 nm, the yellow range around 585–595 nm, and the red-to-near-infrared range around 800–1,000 nm.

Shorter wavelengths are absorbed efficiently but generally penetrate less deeply. Longer wavelengths penetrate further into the dermis and are therefore more suitable for larger or deeper vessels.

Selecting Parameters for Superficial Facial Telangiectasia

Choose shorter wavelengths for fine vessels

For superficial facial vessels, 532 nm KTP, 585–595 nm pulsed-dye lasers, and appropriate IPL filters can provide efficient vascular absorption at shallow depths.

These systems are particularly useful for fine vessels on the cheeks, nasal dorsum, and other areas where the target is close to the skin surface.

Use shorter pulses for small-caliber targets

Small vessels heat and cool more rapidly than large vessels. Pulse durations in the approximate range of 5–10 ms are commonly suited to superficial facial telangiectasia when matched to the device, fluence, spot size, and vessel response.

Some facial applications use even shorter millisecond pulses, depending on the laser platform and the goal of reducing purpura. The correct setting is therefore determined by the clinical endpoint and the manufacturer’s validated parameter range, not by pulse duration alone.

Account for facial anatomy

The nasal ala, nose, and cheeks can contain vessels with different depths, diameters, and degrees of background erythema. A setting that works well on a fine cheek telangiectasia may be inadequate or unnecessarily aggressive on a deeper nasal vessel.

A multi-wavelength platform allows the practitioner to switch from a superficial wavelength for fine vessels to a longer wavelength when deeper or larger vessels are present.

Selecting Parameters for Leg Veins

Favor deeper-penetrating wavelengths

Leg veins generally require more dermal penetration than superficial facial telangiectasia. 755 nm Alexandrite and especially 1,064 nm long-pulsed Nd:YAG systems are commonly considered when the target is deeper, larger, or less responsive to superficial wavelengths.

The 1,064 nm wavelength is particularly useful when the vessel lies beyond the effective penetration range of green or yellow light. Its reduced epidermal melanin absorption relative to shorter wavelengths can also be advantageous, although tissue protection remains essential.

Increase pulse duration with vessel diameter

For leg vessels around 0.2–0.5 mm, pulse durations of approximately 5–20 ms may be appropriate within the capabilities of the system.

Larger vessels around 0.6–1.0 mm generally require longer pulses, commonly in the range of 30–60 ms. Pulse durations near 40 ms are often used as a practical starting region for larger targets, but the final choice must be adjusted to vessel response and patient skin characteristics.

Use larger spot sizes when penetration is needed

Larger spot sizes can reduce relative scattering and improve effective penetration into the dermis. For leg veins, spot sizes of approximately 5–7 mm or larger, when supported by the device and treatment area, may be preferable to very small spots.

Spot size should still be balanced against anatomic contour, vessel visibility, fluence requirements, and the need for precise treatment near sensitive structures.

Match Pulse Duration to Thermal Relaxation

Small vessels need shorter heating intervals

A small vessel has a shorter thermal relaxation time. A pulse that is too long may allow heat to spread beyond the vessel and increase the risk of unnecessary injury to surrounding tissue.

For this reason, superficial facial capillaries and small leg vessels generally respond better to shorter millisecond pulses than large reticular veins.

Large vessels need sustained thermal exposure

Larger vessels contain a greater volume of blood and require heat to propagate across the vessel lumen and wall. Longer pulses allow this heating to occur more gradually and can improve vessel coagulation while limiting an excessively abrupt temperature rise.

A pulse that is too short for a large vessel may produce incomplete coagulation, vessel rupture, or an inconsistent clinical response rather than uniform vessel closure.

Treat pulse duration as a range, not a fixed prescription

The stated ranges are practical guides, not universal prescriptions. Vessel depth, color, blood oxygenation, epidermal melanin, cooling, spot size, fluence, and the specific laser’s pulse profile all affect the final parameter selection.

The intended endpoint should be assessed continuously, with treatment stopped or modified when the response indicates excessive epidermal or perivascular injury.

Adapt Wavelength to Vessel Depth and Blood Characteristics

Deeper vessels require longer wavelengths

When a facial lesion extends into the deeper dermis, a superficial 532 nm or 595 nm treatment may fail to deliver sufficient energy to the target. In those cases, a longer wavelength such as 1,064 nm Nd:YAG may be more appropriate.

This principle also explains why a wavelength that works well for facial microvessels may perform poorly on leg veins.

Consider deoxygenated blood in leg veins

Leg telangiectasias may contain more deoxygenated blood than the relatively superficial facial microvasculature. This can alter the absorption profile and make longer-wavelength systems more useful for selected leg vessels.

The practitioner should evaluate the vessel’s visible color and depth rather than assume that all red or blue vessels will respond identically.

Use sequential wavelengths selectively

Mixed vascular networks may contain both superficial fine vessels and deeper larger veins. In carefully selected cases, sequential use of a superficial wavelength such as 595 nm followed by a deeper wavelength such as 1,064 nm can address different vascular compartments.

Such combinations require careful control of cumulative thermal exposure. They should be used only when the platform, protocol, and clinical endpoint support the approach.

Protect the Epidermis While Reaching the Target

Cooling expands the usable treatment window

Active contact cooling or chilled gel can protect the epidermis while allowing sufficient energy to reach deeper vessels. This is especially important when treating leg veins with longer wavelengths, larger spot sizes, or higher fluences.

Cooling does not eliminate risk. Excessive treatment energy, overlap, or inadequate assessment of skin type can still cause burns, pigmentary change, or scarring.

Consider skin pigmentation

Shorter wavelengths are more strongly absorbed by epidermal melanin and may carry greater pigmentary risk in darker skin types. Longer wavelengths can reduce this competition, but they still require appropriate cooling, conservative parameter selection, and careful patient assessment.

The treatment plan should account for recent tanning, baseline pigmentation, medications, and a history of post-inflammatory hyperpigmentation.

Understanding the Trade-offs

Superficial wavelengths are efficient but limited in depth

Green and yellow wavelengths can be highly effective for superficial facial vessels because they are well absorbed by hemoglobin. Their limitation is reduced penetration, particularly when the target lies deeper or is protected by overlying tissue.

Using them on deeper leg veins can result in inadequate vessel heating while increasing superficial tissue exposure.

Longer wavelengths penetrate deeper but demand more control

The 755 nm and 1,064 nm ranges are better suited to deeper vessels, but deeper penetration does not make treatment automatically safer. These systems can deliver substantial heat to the dermis and require appropriate cooling, pulse duration, fluence, and endpoint monitoring.

A longer wavelength may also be less efficient for the smallest superficial vessels than a well-matched green or yellow wavelength.

Longer pulses can improve coagulation but increase heat spread

Extending the pulse duration helps heat larger vessels throughout their walls. If the pulse is too long, however, heat may diffuse into surrounding tissue and increase the likelihood of blistering, burns, prolonged erythema, or textural change.

Laser is not equally effective for every vessel caliber

Very fine vessels may clear rapidly, while vessels above approximately 0.4 mm can respond less reliably to laser monotherapy. Larger or complex leg-vein networks may require staged treatment, alternative vascular therapies, or a combined treatment strategy.

How to Apply This to Your Project

Parameter selection should be individualized through examination, test spots where appropriate, and response-based adjustment.

If your primary focus is superficial facial telangiectasia: Start by considering 532 nm or 585–595 nm systems with short millisecond pulses, then adjust for vessel caliber, facial location, skin type, and the desired purpura or blanching endpoint.
If your primary focus is deeper or larger leg veins: Prioritize 755 nm Alexandrite or 1,064 nm long-pulsed Nd:YAG systems, larger spot sizes, and longer pulses that increase with vessel diameter.
If your primary focus is mixed vascular anatomy: Use a multi-wavelength platform so superficial and deep vessel compartments can be treated with separate, controlled parameter sets.
If your primary focus is minimizing adverse effects: Give equal attention to cooling, pulse overlap, fluence, skin pigmentation, and cumulative thermal exposure rather than selecting wavelength and pulse duration in isolation.

The most reliable treatment decisions come from matching wavelength to depth and absorption, and matching pulse duration to vessel diameter and thermal relaxation time.

Summary Table:

Target Vessel	Wavelength	Pulse Duration	Key Considerations
Superficial Facial Telangiectasia	532 nm KTP, 585–595 nm PDL, IPL	5–10 ms	Shallow, small vessels; short pulses minimize purpura; protect epidermis with cooling.
Leg Veins (deeper, larger)	755 nm Alexandrite, 1064 nm Nd:YAG	5–20 ms (smaller), 30–60 ms (larger)	Deeper penetration needed; longer pulses for larger vessels; use larger spot sizes; adapt to deoxygenated blood.

Elevate your practice with BELIS' advanced multi-wavelength vascular laser systems. Our professional-grade platforms are designed for clinics and premium salons, offering precision and safety for treating both superficial facial telangiectasia and leg veins. Contact our experts today to discover how our cutting-edge technology can enhance your patient outcomes and grow your business. Contact us now to schedule a consultation!